Zentalis Pharmaceuticals(ZNTL)
$1.70+0.02 (+1.19%)
ZNTL
Zentalis Pharmaceuticals financials statements
$1.70
At close:+0.02 (+1.19%)
Want to see ZNTL full AI Analyst Report?
Zentalis Pharmaceuticals (ZNTL) Income Statement
418 Followers
Zentalis Pharmaceuticals Income Statement
Last quarter (Q3 2026), Zentalis Pharmaceuticals's total revenue was $0.00. In Q3, Zentalis Pharmaceuticals's net income was $-28.82M. See Zentalis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 67.42M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 67.42M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 152.81M | $ 258.62M | $ 299.51M | $ 227.29M | $ 216.54M | |
| Depreciation and Amortization | $ 739.00K | $ 1.29M | $ 1.39M | $ 1.43M | $ 544.00K |
| $ -144.27M | $ -186.17M | $ -247.60M | $ -233.58M | $ -207.20M | |
| $ -152.81M | $ -191.19M | $ -299.51M | $ -227.29M | $ -216.54M | |
| $ 16.19M | $ 25.50M | $ 6.60M | $ -10.29M | $ 50.15M | |
| $ -136.62M | $ -165.69M | $ -292.91M | $ -237.58M | $ -166.39M | |
| $ -137.06M | $ -165.84M | $ -292.19M | $ -236.81M | $ -158.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.91 | $ -2.33 | $ -4.47 | $ -4.48 | $ -3.72 |
| Diluted EPS | $ -1.91 | $ -2.33 | $ -4.47 | $ -4.48 | $ -3.72 |
| Weighted Average Shares Outstanding | 71.87M | 71.08M | 65.41M | 52.86M | 42.69M |
| Weighted Average Shares Outstanding (Diluted) | 71.87M | 71.08M | 65.41M | 52.86M | 42.69M |
Currency in USD
